HORMONAL HARMONY
Natural health product licensed in Canada
- Other names
- AEGIS, EDUN FOR MEN, EDUN FOR WOMEN, XYLACEL
- Licence holder
- Nokomis Research Inc.
- NPN or DIN-HM
- 80088450
- Status
- Active licence
- Licence date
- 25 September 2018
- Revision date
- 4 June 2024
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Raphanus sativus Source : Feuilles | 100 milligramme | Not calculated |
| 3,3'-diindolylméthane Source : Synthétique | 60 milligramme | Not calculated |
Non-medicinal ingredients
Hypromellose, Cellulose microcristalline, Stéarate de magnésium, Carbonate de calcium, Huile végétale hydrogénée, Dioxyde de silicium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Comprimé | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Source of / An antioxidant for the maintenance of good health. Source of / An antioxidant that helps protect against oxidative stress. Source of / An antioxidant that helps (to): a) fight / b) protect (cells) against / c) reduce (the oxidative effect of / the oxidative damage caused by / cell damage caused by) free radicals. Helps to maintain normal function of the thyroid glan. Helps to support/promote healthy estrogen metabolism/balance. Helps reduce the severity and duration of symptoms associated with recurrent breast pain (cyclical mastalgia).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80088450
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2024. Photograph the packaging to check whether it has changed. Photograph the packaging